Modus Therapeutics Stock Forward View
| MODTX Stock | 0.28 0.01 3.70% |
News-driven analysis for Modus Therapeutics seeks to separate meaningful signals from market noise. By filtering relevant headlines and sentiment trends, this module identifies potential catalysts that may move Modus Therapeutics' price.
At the latest evaluation, Modus Therapeutics posts RSI reading of 43, reflecting mild downside bias. Momentum below the midline but above oversold territory places Modus Therapeutics in a wait-and-see zone for many technical traders.Momentum
Sell Extended
Oversold | Overbought |
This view frames how Modus Therapeutics Holding responds to recent headlines and peer activity within its market context.
The Naive Prediction forecasted value of Modus Therapeutics Holding on the next trading day is expected to be 0.26 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.59.Modus Therapeutics after-hype prediction price | kr 0.27 |
This view adds attention context to forecasting, technical signals, analyst estimates, and earnings data.
Modus |
Modus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Modus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Modus using various technical indicators. When you analyze Modus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Naive Prediction Price Forecast For the 17th of March 2026
Given 90 days horizon, the Naive Prediction forecasted value of Modus Therapeutics Holding on the next trading day is expected to be 0.26 with a mean absolute deviation of 0.01 , mean absolute percentage error of 0.0002 , and the sum of the absolute errors of 0.59 .Please note that although there have been many attempts to predict Modus Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Modus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Modus Therapeutics | Modus Therapeutics Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Modus Therapeutics Holding uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. The current forecast range spans downside near 0.0028 and upside near 5.06.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Modus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Modus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.578 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0097 |
| MAPE | Mean absolute percentage error | 0.0313 |
| SAE | Sum of the absolute errors | 0.594 |
Mean reversion in Modus Therapeutics is more reliable over longer time horizons. Short-term deviations can persist and even widen before correcting, making position sizing and risk management critical.
After-Hype Price Density Analysis
Investors who rely solely on expected value estimates for Modus Therapeutics miss the full picture. Modus Therapeutics' probability distribution reveals that expected value can be achieved through very different combinations of outcomes, each with different risk implications.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The after-news price analysis for Modus Therapeutics is built on the observation that Modus Therapeutics' market reactions to news are not random but follow recognizable patterns. Modus Therapeutics' after-hype downside and upside margins for the prediction period are 0.01 and 5.08, respectively. Identifying and quantifying these patterns for Modus Therapeutics is the core purpose of this model.
Current Value
Macroaxis estimates the after-hype price of Modus Therapeutics Holding across a 3 months horizon to evaluate where the instrument could settle once headline distortion subsides. The objective is to separate event-driven enthusiasm from a more stable price path once the market absorbs the catalyst.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Modus Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Modus Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Modus Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 4.80 | 0.00 | 0.00 | 0 Events | 0 Events | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.28 | 0.27 | 0.00 |
|
Hype Timeline
Modus Therapeutics is now traded for 0.28on Stockholm Exchange of Sweden. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Modus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at -0.26%. %. The volatility of related hype on Modus Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.28. About 79.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.57. Modus Therapeutics had not issued any dividends in recent years. Assuming the 90-day trading horizon the next projected press release will be uncertain. Historical Fundamental Analysis of Modus Therapeutics provides a cross-check on projections for Modus Therapeutics. The analysis adds historical context for the projection set.Related Hype Analysis
The information ratio and semi-deviation metrics in the peer comparison table for Modus Therapeutics provide a risk-adjusted view of how efficiently Modus Therapeutics' competitors convert news exposure into returns relative to downside risk.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EXPRS2 | ExpreS2ion Biotech Holding | 0.00 | 0 per month | 0.00 | -0.16 | 5.92 | -9.86 | 68.29 | |
| 2CUREX | 2cureX AB | 0.00 | 0 per month | 9.27 | 0.09 | 13.99 | -16.60 | 168.09 | |
| AINO | Aino Health AB | 0.00 | 0 per month | 0.00 | -0.02 | 6.67 | -10.53 | 32.65 | |
| GUARD | Guard Therapeutics International | 0.00 | 0 per month | 4.50 | 0.09 | 11.73 | -7.09 | 30.94 | |
| EPIS-B | Episurf Medical AB | 0.00 | 0 per month | 6.70 | 0.12 | 22.92 | -9.88 | 56.29 | |
| STABL | Stayble Therapeutics AB | 0.00 | 0 per month | 0.00 | -0.08 | 8.33 | -8.70 | 27.38 | |
| SIMRIS-B | Simris Alg AB | 0.00 | 0 per month | 11.62 | 0.07 | 15.79 | -14.29 | 104.57 | |
| FLUI | Fluicell AB | 0.00 | 0 per month | 5.10 | 0.05 | 12.07 | -8.11 | 34.82 | |
| QLIFE | Qlife Holding AB | 0.00 | 0 per month | 5.35 | 0.13 | 19.91 | -10.00 | 63.69 | |
| LPGO | Lipigon Pharmaceuticals AB | 0.00 | 0 per month | 10.24 | 0.01 | 18.75 | -19.35 | 118.05 |
Other Forecasting Options for Modus Therapeutics
For investors considering Modus, Modus Therapeutics' price movement is the most direct driver of investment returns. Noise in Modus Stock price charts can make identifying meaningful trends difficult without dedicated analytical tools.Modus Therapeutics Related Equities
The following equities are related to Modus Therapeutics within the Biotechnology space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Modus Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Modus Therapeutics Market Strength Events
Market strength indicators for Modus Therapeutics provide investors with a view of how the stock performs across different market environments. By analyzing these indicators, traders can determine the best moments to enter or exit positions in Modus Therapeutics Holding.
Modus Therapeutics Risk Indicators
A structured analysis of Modus Therapeutics' risk indicators is one of the most reliable ways to improve the accuracy of price forecasts. Understanding the risk embedded in Modus Therapeutics' allows investors to decide whether to accept, reduce, or hedge their exposure.
| Mean Deviation | 3.34 | |||
| Standard Deviation | 4.75 | |||
| Variance | 22.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Modus Therapeutics
Story coverage around Modus Therapeutics Holding often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Modus Therapeutics Short Properties
Short-interest signals around Modus Therapeutics Holding can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 12.4 M | |
| Cash And Short Term Investments | 20.6 M |
Additional Tools for Modus Stock Analysis
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |